Aveo Pharmaceuticals Inc (AVEO) Inventory Turnover Ratio, from third quarter 2022 to third quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Aveo Pharmaceuticals Inc   (AVEO)
 

Aveo Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aveo Pharmaceuticals Inc inventory turnover ratio, the Aveo Pharmaceuticals Inc 's ability to sell and replace its inventory in the third quarter 2022, sequentially increased to 7.96 in the third quarter 2022, a new company high. Average inventory processing period, for the Aveo Pharmaceuticals Inc in Sep 30 2022 quarter, has decreased to 46 days, compare to 58 days, in the Jun 30 2022 quarter.

Within Healthcare sector 52 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2022, to 527, from total ranking in the second quarter 2022 at 693.

AVEO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aveo Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVEO Inventory Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Inventory Growth -11.66 % - - - -
Y / Y Cost of Sales Growth 127.29 % 272.87 % 1663.77 % - -
Inventory Turnover Ratio (TTM) 7.96 6.27 6.11 6.52 8.64
AVEO's Total Ranking # 527 # 693 # 522 # 0 # 0
Average inventory processing period 46 58 60 56 42
Seq. Inventory Growth -16.21 % -22.08 % 2.29 % 32.27 % -
Seq. Cost of Sales Growth 29.33 % 25.92 % 19.72 % 16.57 % 112.17 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 19
Healthcare Sector # 53
Overall Market # 527

Inventory Turnover Ratio Statistics
High Average Low
7.96 7.11 6.27
(Sep 30 2022)   (Jun 30 2022)



AVEO Company Profile >> Back to AVEO Efficiency Comparisons >> Compare AVEO Inventory Turnover Ratio to its Competitors

Financial Statements
Aveo Pharmaceuticals Inc 's Inventories $ 1 Millions Visit AVEO's Balance sheet
Aveo Pharmaceuticals Inc 's Cost of Revenues TTM $ 11 Millions Visit AVEO's Income Statement
What are AVEO's Sales? Visit AVEO's Sales by Segment

Other Inventory Turnover Ratios
Aveo Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AVEO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AVEO's Competitors
Inventory Turnover Ratio for AVEO's Suppliers
Inventory Turnover Ratio for AVEO's Customers

You may also want to know
AVEO's Sales Growth Rates AVEO's Pe Price to earnings ratio AVEO's Receivables Turnover Ratio AVEO's Stock Quote
AVEO's Net Income Growth Rates AVEO's Ps Price to Sales ratio AVEO's Sales per Employee AVEO's Asset Turnover Ratio
AVEO's Net Margin AVEO's Pb Price to Book ratio AVEO's Financial Strength Ratios AVEO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2022 Inventories at quarter ending Sep 30 2022
Cormedix Inc   26.98 $ 0.051  Millions$ 0  Millions
Intelgenx Technologies Corp   25.89 $ 2.039  Millions$ 0  Millions
Labcorp Holdings Inc   23.98 $ 10,468.400  Millions$ 437  Millions
The Oncology Institute Inc   23.87 $ 195.780  Millions$ 8  Millions
Rennova Health Inc   21.99 $ 5.988  Millions$ 0  Millions
Adapthealth Corp   21.70 $ 2,445.467  Millions$ 113  Millions
Vaso Corporation  20.57 $ 31.733  Millions$ 2  Millions
Viemed Healthcare Inc   18.87 $ 51.840  Millions$ 3  Millions
Aspira Women s Health inc   18.15 $ 3.785  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   17.98 $ 24.280  Millions$ 1  Millions
Harmony Biosciences Holdings inc   17.37 $ 74.414  Millions$ 4  Millions
Biocept Inc   14.03 $ 35.138  Millions$ 3  Millions
Option Care Health Inc   13.81 $ 2,996.682  Millions$ 217  Millions
Natera Inc   13.53 $ 415.522  Millions$ 31  Millions
Rockwell Medical inc   13.38 $ 66.212  Millions$ 5  Millions
Dermtech Inc   13.34 $ 13.561  Millions$ 1  Millions
Prophase Labs Inc   13.26 $ 61.992  Millions$ 5  Millions
23andme Holding Co  12.00 $ 159.539  Millions$ 13  Millions
Myriad Genetics Inc   11.77 $ 193.900  Millions$ 16  Millions
Dmk Pharmaceuticals Corporation  11.69 $ 5.795  Millions$ 0  Millions
Precipio inc   11.54 $ 6.899  Millions$ 1  Millions
Rvl Pharmaceuticals Plc  11.30 $ 7.979  Millions$ 1  Millions
Invitae Corporation  10.79 $ 420.518  Millions$ 39  Millions
Sunlink Health Systems Inc   10.48 $ 19.403  Millions$ 2  Millions
Infusystem Holdings Inc  10.44 $ 45.803  Millions$ 4  Millions
Clene Inc   10.16 $ 0.569  Millions$ 0  Millions
Sotera Health Company  10.05 $ 444.109  Millions$ 44  Millions
Cryo cell International Inc   9.83 $ 8.949  Millions$ 1  Millions
Irhythm Holdings Inc   9.76 $ 125.900  Millions$ 13  Millions
Semler Scientific inc   9.61 $ 5.236  Millions$ 1  Millions

Date modified: 2026-08-29T17:23:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.